TARGET
saveJAK
Janus kinase family; autoimmune and MPN target.
also known as: jak1, jak2, jak3, janus kinase
🐶 often sniffed alongside
top 7drugs
0
catalysts
0
news
129
companies
0
Top drugs
no drugs tagged with this interest yet
🐶 Top companies
no companies tagged with this interest yet
Recent catalysts
no catalysts tagged with this interest yet
Recent news
view all →- Lilly adds to buyout streak with $1.5B purchase of startup Calytrixbiopharma dive · 3d ago
- Lilly secures another myelofibrosis option via $1.5B deal for JPM-founded Calytrixfiercebiotech · 3d ago
- Aclaris drops TSLP program from pipeline after flunking phase 2 eczema testfiercebiotech · 3d ago
- Evommune inks molecular glue deal worth $1.1B biobucks to fill pipeline gapbiospace · 14d ago
- Alethio raises $90M to target rare blood cancersbiopharma dive · 14d ago
- Evommune signs $1B deal with China’s Hinova to enter same molecular glue niche as Novartisfiercebiotech · 14d ago
- Geron’s Rytelo stumbles in phase 3 as Novartis gears up for post-JAK inhibitor blood cancer bidfiercebiotech · 22d ago
- ESMO: Why Incyte sees itself ‘neck and neck’ with RevMed in KRAS G12D pancreatic cancer racefiercebiotech · 25d ago
Data sources
last refreshed 1h ago
Found something off?
comments(0)
5-min edit window · permanent after that